Forte Biosciences, Inc.
NCM: FBRXLive Quote
📈 ZcoreAI Score
Our AI model analyzes Forte Biosciences, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get FBRX Z-Score →About Forte Biosciences, Inc.
Healthcare
Biotechnology
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
📊 Fundamental Analysis
Forte Biosciences, Inc. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.
Return on Equity (ROE) is -122.3%, which indicates that capital utilization is currently under pressure.
At a current price of $35.09, FBRX currently trades near the top of its 52-week range (98%) (Range: $4.90 - $35.80).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$487.25M
Trailing P/E
--
Forward P/E
-8.12
Beta (5Y)
3.20
52W High
$35.80
52W Low
$4.90
Avg Volume
277K
Day High
Day Low